Surgical Innovation Associates
Chicago, US · Delaware corporation · 1 known investors
Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support
Healthtech
Founders & leadership
AM
Alexei MlodinowFounder30 Under 30 2019
JO
Jason O'HearnChief Commercial Officer
JS
John SlumpChief Financial Officer
TC
Todd CruikshankExecutive
JY
John Y.S. Kim, M.D.Named on SEC filing
Board
RE
Ryan EgelandBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 5 rounds · 2016–2021
▶$4.8MraisedApr 2021 · 59 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2021 · 59 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason O'HearnExecutive Officer
- Ryan EgelandDirector
- John Y.S. Kim, M.D.Director
- Alexei MlodinowExecutive Officer, Director
- John SlumpExecutive Officer
- Todd CruikshankExecutive Officer
- Amount sold
- $4.8M
- Minimum investment
- $50K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedJun 2020 · 39 investors · Other Health CareRule 506(b)
▶$1.7MraisedJun 2020 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Y.S. Kim, M.D.Director
- Ryan EgelandDirector
- Alexei MlodinowExecutive Officer, Director
- Todd CruikshankExecutive Officer
- John SlumpExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.7M
- Proceeds to insiders
- $541.1K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.3MraisedApr 2019 · 15 investors · Other Health CareRule 506(b)
▶$1.3MraisedApr 2019 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Todd CruikshankExecutive Officer
- Alexei MlodinowExecutive Officer, Director
- John Y.S. Kim, M.D.Director
- Offering amount
- $4M
- Amount sold
- $1.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$325KraisedMar 2018 · 3 investors · Other Health CareRule 506(b)
▶$325KraisedMar 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexei MlodinowExecutive Officer, Director
- Todd CruikshankExecutive Officer
- John Y.S. Kim, M.D.Director
- Offering amount
- $1.5M
- Amount sold
- $325K
- Minimum investment
- $10K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$748KraisedJul 2017 · 18 investors · Other Health CareRule 506(b)
▶$748KraisedJul 2017 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexei MlodinowExecutive Officer, Director
- John Y.S. Kim, M.D.Director
- Todd CruikshankExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $748K
- Minimum investment
- $10K
- Proceeds to insiders
- $60K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Surgical Innovation Associates do?
- Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support
- Who founded Surgical Innovation Associates?
- Surgical Innovation Associates was founded by Alexei Mlodinow.
- Who are Surgical Innovation Associates's investors?
- Surgical Innovation Associates's investors include First Leaf Capital.
- How much funding has Surgical Innovation Associates raised?
- Surgical Innovation Associates has disclosed $8.9M raised across 5 rounds.
- Where is Surgical Innovation Associates headquartered?
- Surgical Innovation Associates is headquartered in Chicago, US.